Studying a weight-loss medicine for cannabis use disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether tirzepatide, a medicine used for diabetes and weight loss, can help reduce cannabis use in people with moderate to severe cannabis use disorder. If you qualify, you would take the medicine for a period and track your cannabis use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with moderate or severe cannabis use disorder.
- You want treatment for your cannabis use.
- You can read and understand English and follow study procedures.
- If you are female, you are not pregnant, and you agree to use birth control.
- Your body mass index (BMI) is above 23 (so you are not underweight).
- You are not currently using other weight-loss drugs or GLP-1 medicines, and have not been in substance use treatment in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tirzepatide, a medicine used for type 2 diabetes and weight loss, can help people with severe cannabis use disorder cut down or quit. It may reduce cravings and other symptoms of withdrawal.
This trial tests whether a medication called semaglutide (used for weight management) can help adults with cannabis use disorder cut down or stop using cannabis. Researchers want to see if it reduces cravings and use while also monitoring overall health.
This study tests if helping people reduce heavy cannabis use improves daily life. It's for adults with cannabis use disorder who want to cut back.
This study looks at how cannabis affects your brain's reward system using MRI scans. It aims to understand why some people develop cannabis use disorder, which may lead to better treatments.
This trial tests whether a treatment called repetitive transcranial magnetic stimulation (a non-surgical magnetic stimulation to the brain) can help people reduce or stop cannabis use. You may be eligible if you have cannabis use disorder and meet specific safety and symptom criteria.
This study tests whether a weekly injection called tirzepatide (a drug used for diabetes and weight loss) can help people reduce their cannabis use. If you're interested in cutting down and have a higher body weight, this trial might offer a new approach.
Hear when a new Cannabis Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.